MERCK NUCLEOSIDE. Single nucleosides, nucleotides or monomers claimed in Patents filed as of the Effective Date which are prosecuted by Merck and Co. are excluded. However if such Patents are necessary for Alnylam to practice the licenses granted under Section 5.1 with respect to a specific Alnylam Product, then Isis will include such necessary Patents in the licenses granted under Section 5.1.
Appears in 4 contracts
Samples: Strategic Collaboration And (Alnylam Pharmaceuticals, Inc.), License Agreement (Isis Pharmaceuticals Inc), Collaboration and License Agreement (Alnylam Pharmaceuticals Inc)